News
This Driverless Cars Stock Is Ridiculously Cheap
Typically, the cheapest stocks in the S&P 500 are cheap for a reason. Usually, they have some kind of existential issue they need to overcome in order to regain investors' faith and a more reasonable
Blue Chip Stocks in Focus: Emerson Electric
Published by Nick McCullum on July 25th, 2017
At Sure Dividend, we define blue chip stocks as companies with 100+ year operating histories and 3%+ dividend yields.
While there is no ‘perfect’
Google Continues to Push Higher in the Cloud
Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) reported second-quarter earnings last night, and while the results came in ahead of expectations, investors weren't all that impressed; shares are down 3% today
Blue Chip Stocks In Focus: Verizon
Published by Bob Ciura on July 25th, 2017
When investors consider buying high-quality stocks, the term ‘blue chip’ often comes to mind.
There is no official definition of what constitutes a
Blue Chip Stocks In Focus: General Electric
Published by Bob Ciura on July 25th, 2017
Blue chip stocks generally have a reputation for high-quality businesses, steady profits, and reliable dividends.
While there is no exact definition
Nucor Corporation Delivers Best First-Half Profits Since Great Recession: Here's How
Over the past several years, steel demand in the U.S. has been at some of the highest levels in a decade. But at the same time, imported steel -- which the U.S. steel industry has argued was largely
What Happened in the Stock Market Today
It was a positive day on Wall Street, with the Dow Jones Industrial Average (DJINDICES: ^DJI) gaining 100 points and the S&P 500 (SNPINDEX: ^GSPC) setting a record high.Data source: Yahoo! Finance.The
Why Allegheny Technologies Stock Just Jumped 10%
Shares of aerospace components and specialty metals maker Allegheny Technologies (NYSE: ATI) stock are up 10.4% as of 2:55 p.m. EDT.Allegheny Technologies -- which despite the name is anything but a
Why Shares of Supervalu Are Surging 14% After its First-quarter Results
Shares of SUPERVALU Inc. (NYSE: SVU), a grocery leader serving customers through a network of more than 2,000 owned, franchised and independently owned stores across the country, are receiving some
Despite Softening Sales General Motors Protects Bottom Line to Beat Estimates
Tuesday brought investors the first of the Detroit automakers' second-quarter earnings with General Motors (NYSE: GM) managing to beat analyst estimates on the bottom line, despite a weaker top line
Why Shares of Scientific Games Corp. Popped 15% Today
Shares of Scientific Games Corp. (NASDAQ: SGMS) jumped as much as 14.9% in trading Tuesday after an analyst upgrade. This comes a day after the stock jumped on a stronger-than-expected earnings report
Why Seagate Technology, Interpublic Group, and Community Health Systems Slumped Today
Wall Street was in a celebratory mood on Tuesday, with gains throughout many key financial markets. Climbing stock prices came in part as a result of a rebound in commodities like oil and base metals
Why Caterpillar, SUPERVALU, and Freeport-McMoRan Jumped Today
Tuesday was a strong day for stocks, and major benchmarks climbed toward record highs by the end of the session. In particular, two favorable earnings reports from major components of the Dow Jones
Why McDonald's Corporation Stock Popped Today
McDonald's Corporation (NYSE: MCD) stock gained 4.8% on Tuesday after the fast food juggernaut announced better-than-expected second-quarter 2017 results.Quarterly revenue declined 3.4% year over year
GROUPE LDLC : Mise à disposition du Document de Référence au 31 mars 2017
Le document de référence au 31 mars 2017 du Groupe LDLC a été enregistré auprès de l'Autorité des marchés financiers (AMF) le 25 juillet 2017 sous le numéro R.17-056.
Ce document est....
5 Things PepsiCo's Management Wants You to Know
Though PepsiCo's (NYSE: PEP) revenue has remained flat over the last five years, the company's stock has posted a cumulative total return of 92% over the same period. Part of investors' confidence in
NVR's Second-Quarter Earnings Get a Boost From America's Hottest Real Estate Markets
What's that tired phrase when it comes to real estate? Location, location, location. Luckily for homebuilder NVR (NYSE: NVR), the hot housing markets are headed back East into NVR's wheelhouse. Those
New Oriental Education & Tech Grp (ADR) Has Established Undeniable Momentum
In the world of for-profit education, there are two metrics to watch: enrollment figures and how efficiently schools are winning over students. The former is pretty straightforward, while the latter
3 Potential Replacements for Intel Corporation's CEO
In a recent column, I provided just three of the many reasons I believe Intel (NASDAQ: INTC) needs new management.Although I have reason to believe Intel's management problems run deeper than just a
IMAX Stock Has a Lot to Prove on Wednesday
There hasn't been a Hollywood ending for IMAX (NYSE: IMAX) investors. The provider of enhanced theatrical experiences hit a four-year low last week, and the pessimism comes just as IMAX is about to
3 Dividend Stocks That Are Perfect for Retirement
If you're at the point in your investing life where you're adjusting your portfolio from higher-risk growth mode toward a safer asset allocation -- one designed to support you dependably through your
SELECTIRENTE : Activité et résultats du 1er semestre 2017
Evry, le 25 juillet 2017,
Stabilité des loyers
Un taux d'occupation du patrimoine immobilier de plus de 95 %
Le chiffre d'affaires de SELECTIRENTE ressort à 7,4 M€ au 1er semestre 2017, en....
ORCLASS.COM : Précisions suite à des rumeurs infondées sur l'activité et à la forte variation du cours de bourse
OrClass.com, acteur majeur du rachat d'or par Internet en France, a constaté une chute importante du cours suite à des ordres de vente à tout prix et à une faible liquidité.
OrClass.com....
An Exciting New Drug Is in Clinical Trials for Aurinia Pharmaceuticals
Richard Glickman was the CEO of Aspreva Pharmaceuticals, which put out CellCept, a drug that treats patient with lupus who develop kidney disease. Glickman has moved on to Aurinia Pharmaceuticals
An Exciting New Drug Is in Clinical Trials for Aspreva Pharmaceuticals
Richard Glickman was the CEO of Aspreva Pharmaceuticals, which put out CellCept, a drug that treats patient with lupus who develop kidney disease. Glickman has moved on to Aurinia Pharmaceuticals